Edit
Vigene Biosciences, A Charles River Company
https://www.vigenebio.com/Last activity: 29.06.2021
Active
Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy. At Vigene, we strive to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable. We offer both research-grade and cGMP-grade AAV, lentivirus, and adenovirus-based products and custom services. Some of our product offerings include ready-to-ship genome wide human cDNA ORFs on adenoviral or lentiviral vectors, AAV shRNA constructs, pre-made control GFP viruses, AAV biosensors developed in partnership with Janelia Research Campus, AAV alpha-synuclein vectors developed in partnership with The Michael J Fox Foundation, and many others.
For more information, visit our websites for research (www.vigenebio.com) or cGMP (www.vigenegmp.com) services.
You can also follow us on twitter at @VigeneBio.
For more information, visit our websites for research (www.vigenebio.com) or cGMP (www.vigenegmp.com) services.
You can also follow us on twitter at @VigeneBio.
Location: United States, Maryland, Rockville
Employees: 51-200
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
| - | Signet Hea... | signetheal... |
Mentions in press and media 3
| Date | Title | Description |
| 29.06.2021 | M&A Moves: 2U acquired edX for $800M from Harvard, MIT | M&A Moves is a Technical.ly column where we highlight D.C.-area companies completing mergers and making acquisitions to scale their businesses. Have a submission? Email us at dc@technical.ly and tell us why it belongs in the roundup. La... |
| 11.02.2021 | Vigene Biosciences goes big on Maryland viral vector expansion as it rides high on Altimmune vaccine deal | Boosted by a gangbusters year for Rockville-based Emergent BioSolutions and its viral vectors for Covid-19 vaccines, the state of Maryland has continued to cement its place as a hotbed for next-gen manufacturing. Now, a smal... |
| 29.04.2019 | Vigene Biosciences Receives Growth Capital Financing | Vigene Biosciences, a Rockville, MD-based provider of viral vector products and services used in gene therapy, completed a substantial growth capital financing transaction of undisclosed amount. The investment was made by Signet Healthcare ... |